SOLTI is a leading group in clinical cancer research in Spain. With a solid 30-year track record, its main activity focuses on designing and conducting academically based translational clinical trials. While primarily focused on breast cancer, it has expanded its scope to other tumors.

SOLTI has accumulated experience in 115 clinical trials and has more than 30 currently in progress. It is composed of 550 researchers across a network of 100 centers in Spain, Portugal, and Ireland, coordinated by a central office in Barcelona where a team of more than 80 people works.

SOLTI is part of the Spanish Society of Medical Oncology (SEOM) and is a non-profit association that, in addition to its scientific work, has a Medical Education and patient education program with multiple annual initiatives. SOLTI’s mission is to promote disruptive, innovative research that improves the well-being and prognosis of cancer patients.

Find out more about us on our social media and website: